Published in FASEB J on April 01, 1990
Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A (2003) 5.11
The regulation of reactive oxygen species production during programmed cell death. J Cell Biol (1998) 2.62
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci U S A (2003) 2.21
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem (2005) 1.95
Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem (2007) 1.90
The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal (2012) 1.64
Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem (2003) 1.61
HDAC4 inhibits cell-cycle progression and protects neurons from cell death. Dev Neurobiol (2008) 1.56
Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke (2005) 1.56
Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J Biol Chem (2008) 1.47
Hydroxamate-based histone deacetylase inhibitors can protect neurons from oxidative stress via a histone deacetylase-independent catalase-like mechanism. Chem Biol (2015) 1.42
Expression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tissue Res (2006) 1.32
System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol (2012) 1.27
Characterization of the potent neuroprotective properties of the natural vitamin E alpha-tocotrienol. J Neurochem (2006) 1.26
Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ (2011) 1.25
Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev (2012) 1.21
Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry (2011) 1.20
Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange. J Physiol (1999) 1.18
Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell Death Differ (2010) 1.15
12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress. J Neurochem (2009) 1.13
Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic Biol Med (2010) 1.13
Selective inhibition of mitogen-activated protein kinase phosphatases by zinc accounts for extracellular signal-regulated kinase 1/2-dependent oxidative neuronal cell death. Mol Pharmacol (2008) 1.06
Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity. J Neurochem (2005) 1.05
Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury. Ann N Y Acad Sci (2008) 1.04
Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest (2010) 1.04
Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway. J Cereb Blood Flow Metab (2010) 1.02
Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc Natl Acad Sci U S A (1998) 1.01
Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies. Cell Calcium (2010) 1.00
Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke. J Clin Invest (2008) 0.99
Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injury. Glia (2010) 0.97
Requirement for cGMP in nerve cell death caused by glutathione depletion. J Cell Biol (1997) 0.96
Nuclear factor erythroid 2-related factor 2 facilitates neuronal glutathione synthesis by upregulating neuronal excitatory amino acid transporter 3 expression. J Neurosci (2011) 0.95
Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front Cell Neurosci (2015) 0.93
A chemical compound commonly used to inhibit PKR, {8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one}, protects neurons by inhibiting cyclin-dependent kinase. Eur J Neurosci (2008) 0.93
Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke. Antioxid Redox Signal (2011) 0.91
Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes. J Neurochem (2011) 0.91
Glutamate transporters in the biology of malignant gliomas. Cell Mol Life Sci (2013) 0.90
HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease. Antioxid Redox Signal (2010) 0.90
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies. J Med Chem (2014) 0.89
Lipoxygenase: an emerging target for stroke therapy. CNS Neurol Disord Drug Targets (2013) 0.88
Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity. J Neurochem (2013) 0.88
Induction of neuronal cell death by paraneoplastic Ma1 antigen. J Neurosci Res (2010) 0.86
Role of glutamate transporters in redox homeostasis of the brain. Neurochem Int (2014) 0.86
Promise of neurorestoration and mitochondrial biogenesis in Parkinson's disease with multi target drugs: an alternative to stem cell therapy. Exp Neurobiol (2013) 0.85
Mechanisms of ferroptosis. Cell Mol Life Sci (2016) 0.84
Seizure-induced oxidative stress in temporal lobe epilepsy. Biomed Res Int (2015) 0.83
Yokukansan, a kampo medicine, protects PC12 cells from glutamate-induced death by augmenting gene expression of cystine/glutamate antiporter system Xc-. PLoS One (2014) 0.80
Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.79
Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke. Antioxid Redox Signal (2015) 0.79
Mitochondrial biogenesis and neural differentiation of human iPSC is modulated by idebenone in a developmental stage-dependent manner. Biogerontology (2017) 0.78
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage. Front Cell Neurosci (2016) 0.78
Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier? J Bioenerg Biomembr (2014) 0.78
Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice. Neurochem Int (2014) 0.77
The role of vitamin e in human health and some diseases. Sultan Qaboos Univ Med J (2014) 0.77
Cellular glutathione content in the organ of Corti and its role during ototoxicity. Front Cell Neurosci (2015) 0.77
PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats. Theranostics (2016) 0.75
Glutamate transporters in brain ischemia: to modulate or not? Acta Pharmacol Sin (2014) 0.75
The importance of the excitatory amino acid transporter 3 (EAAT3). Neurochem Int (2016) 0.75
Glutamate oxaloacetate transaminase enables anaplerotic refilling of TCA cycle intermediates in stroke-affected brain. FASEB J (2017) 0.75
Hijacking microglial glutathione by inorganic arsenic impels bystander death of immature neurons through extracellular cystine/glutamate imbalance. Sci Rep (2016) 0.75
Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status. J Biol Chem (2016) 0.75
Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells. Front Pharmacol (2017) 0.75
Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Alzheimer's disease: a disorder of cortical cholinergic innervation. Science (1983) 4.40
Neurology and psychiatry: closing the great divide. Neurology (2000) 3.68
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry (2001) 3.20
The glutamatergic basis of human alcoholism. Am J Psychiatry (1995) 3.20
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol (1981) 3.18
Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron (1989) 3.06
Studies on the biochemical basis of spontaneous mutation. II. The incorporation of a base and its analogue into DNA by wild-type, mutator and antimutator DNA polymerases. J Mol Biol (1974) 2.79
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66
Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol (1996) 2.56
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry (1999) 2.44
D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry (1998) 2.36
Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Mol Pharmacol (1971) 2.08
Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature (1976) 2.08
Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol (1994) 2.05
Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther (1969) 1.99
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (2008) 1.88
Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science (1969) 1.81
Dopaminergic dsyfunction in Tourette syndrome. Ann Neurol (1982) 1.79
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience (1991) 1.78
The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med (1998) 1.72
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry (1995) 1.71
Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc Natl Acad Sci U S A (1998) 1.71
Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A (1996) 1.70
Pilot studies of telemedicine for patients with obsessive-compulsive disorder. Am J Psychiatry (1995) 1.66
Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J Biol Chem (1987) 1.64
Adhesion of hepatocytes to immobilized sugars. A threshold phenomenon. J Biol Chem (1979) 1.61
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Catecholamines in fetal and newborn rat brain. J Neurochem (1973) 1.55
Tyrosine hydroxylase in rat brain--cofactor requirements, regional and subcellular distribution. Biochem Pharmacol (1972) 1.49
N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol (1995) 1.47
Response of large and small coronary arteries to nitroglycerin, NaNO 2 , and adenosine. Am J Physiol (1972) 1.47
Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci U S A (1996) 1.46
Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas. J Pharmacol Exp Ther (1969) 1.43
Hydroxychloroquine retinopathy. Ophthalmology (2001) 1.42
Goldenhar's syndrome. Arch Ophthalmol (1991) 1.40
Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder. Pediatrics (1991) 1.40
Specific cell adhesion to immobilized glycoproteins demonstrated using new reagents for protein and glycoprotein immobilization. J Biol Chem (1983) 1.39
High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J Neurochem (2000) 1.34
Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain (2002) 1.34
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc Natl Acad Sci U S A (1979) 1.27
Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res (1986) 1.26
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav (2010) 1.25
In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage. J Comp Neurol (1978) 1.25
Neurotoxic action of kainic acid. J Neurochem (1983) 1.24
Adhesion of chicken hepatocytes to polyacrylamide gels derivatized with N-acetylglucosamine. J Biol Chem (1978) 1.23
Siglecs: a family of sialic-acid binding lectins. Glycobiology (1998) 1.22
Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol (1979) 1.21
Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res (1979) 1.21
Keratoconus and eye rubbing. Am J Ophthalmol (1984) 1.20
Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells. Glycobiology (2000) 1.20
The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J Neurosci (1992) 1.19
Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry (1998) 1.19
The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs. Am J Psychiatry (1970) 1.18
Gangliosides support neural retina cell adhesion. J Biol Chem (1986) 1.17
High affinity binding of the Entamoeba histolytica lectin to polyvalent N-acetylgalactosaminides. J Biol Chem (1995) 1.15
Psychotropic drug use in very young children. JAMA (2000) 1.15
Tumor cell haptotaxis on covalently immobilized linear and exponential gradients of a cell adhesion peptide. Dev Biol (1989) 1.15
Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature (1982) 1.15
Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease. J Neuropathol Exp Neurol (1986) 1.15
The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc Natl Acad Sci U S A (1993) 1.14
Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord (1991) 1.14
Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry (1995) 1.13
Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet (1981) 1.13
Primary degenerative dementia without Alzheimer pathology. Can J Neurol Sci (1986) 1.13
Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem (1997) 1.12
Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice. J Neurochem (1991) 1.11
Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1. J Virol (1990) 1.11
N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem (1984) 1.10
Sialic acid specificity of myelin-associated glycoprotein binding. J Biol Chem (1997) 1.09
Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol (1983) 1.09
Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Comp Neurol (1992) 1.09
Selective destruction of neurons by a transmitter agonist. Science (1977) 1.08
Cell-surface carbohydrates in cell recognition and response. J Leukoc Biol (1986) 1.08
Avoidance conditioning in different strains of rats: neurochemical correlates. Psychopharmacologia (1973) 1.08
Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J Neurochem (1991) 1.08
Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther (1989) 1.07
Molecularly cloned mammalian glucosamine-6-phosphate deaminase localizes to transporting epithelium and lacks oscillin activity. FASEB J (1998) 1.07
Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci (2000) 1.07
Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol (1999) 1.07
Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Brain Res (1976) 1.06
A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. Exp Neurol (2000) 1.06
Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biol Chem (2001) 1.06
Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration. Biochimie (2001) 1.06
Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies. Brain (2004) 1.06
Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry (1980) 1.06
Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem (1998) 1.06
Neurochemical aspects of the ontogenesis of GABAnergic neurons in the rat brain. Brain Res (1976) 1.05
Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand. J Biol Chem (1997) 1.04
Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J (1987) 1.04
The distribution and orientation of noradrenergic fibers in neocortex of the rat: an immunofluorescence study. J Comp Neurol (1978) 1.04
The neurobiologic consequences of Down syndrome. Brain Res Bull (1986) 1.04
Down syndrome, Alzheimer's disease and the trisomy 16 mouse. Trends Neurosci (1988) 1.04
Ganglioside composition is regulated during differentiation in the neuroblastoma X glioma hybrid cell line NG108-15. J Neurosci (1983) 1.04